Group 1: Company Announcements - Newland has established a foreign subsidiary, NovaPay US Inc., and obtained a US MSB license to enhance its global payment business and facilitate cross-border payment operations [3] - Zhejiang Liming's actual controllers have committed not to reduce their shareholdings in the company for one year starting from July 2, 2025 [4] - Tengya Precision has announced that its controlling shareholder and actual controller will not reduce their shareholdings for three months from July 1, 2025, to September 30, 2025 [5] - *ST Yuancheng is under investigation by the China Securities Regulatory Commission for suspected false financial disclosures, which may lead to significant legal consequences [6] - Anglikon has only one innovative drug project currently under research, which is in the I phase of clinical trials [7] - Yongmaotai plans to invest approximately 450 million yuan to build an intelligent manufacturing base for automotive parts in Mexico [8] - Fengfan Co. intends to acquire 100% equity of eight photovoltaic power station project companies for 48 million yuan to streamline its business structure [9] Group 2: Performance Forecasts - Xinhengcheng expects a net profit of 3.3 billion to 3.75 billion yuan for the first half of 2025, representing a year-on-year increase of 50% to 70% [11][12] - SAIC Motor reported a total vehicle sales of 2.0526 million units in the first half of 2025, a year-on-year increase of 12.35% [13] - BAIC Blue Valley's subsidiary saw a 139.73% year-on-year increase in sales for the first half of 2025 [14] - Kids King anticipates a net profit of 120 million to 160 million yuan for the first half of 2025, reflecting a year-on-year growth of 50% to 100% [15] Group 3: Major Contracts - Guoxin Technology has won a bid for an automotive electronic chip project worth 46 million yuan [17] - Ankao Smart Electric has signed two contracts for wind power transmission projects, totaling approximately 79.69 million yuan, which accounts for 7.34% of the company's projected revenue for 2024 [18] Group 4: Shareholding Changes - Wuxi Zhenhua's shareholder, Wuxi Kangsheng, plans to reduce its stake by up to 1%, equivalent to no more than 2.5 million shares [20]

Group 1 - TaiLong Pharmaceutical plans to apply for the registration and issuance of super short-term financing bonds not exceeding 800 million yuan, with a maturity of no more than 270 days, for purposes including replacing bank loans and supplementing working capital [1] - GuoXin Technology won a bid for a 46 million yuan automotive airbag ignition driver chip project, indicating its growing presence in the automotive semiconductor market [1] - GuoMai Technology expects a net profit increase of 60.52% to 100.33% for the first half of 2025, with a projected net profit of 125 million to 156 million yuan [2] Group 2 - ChangAluminum's subsidiary signed a 165 million yuan contract for the customized construction of a clinical and industrial base for a vaccine project, highlighting its involvement in the biopharmaceutical sector [3] - ZhongSalt Chemical acquired exploration rights for natural soda ash in Inner Mongolia for 929,000 yuan, expanding its resource base [4] - Six Kingdom Chemical announced the resignation of its deputy general manager, which may impact its operational strategy [5][6] Group 3 - FuYuan Pharmaceutical received a drug registration certificate for Bisoprolol Amlodipine tablets, indicating its expansion in the hypertension treatment market [7][8] - GuanShi Technology's subsidiary received a government subsidy of 7 million yuan, which is 45.29% of its net profit for the previous year, enhancing its financial position [9] - XiZhong Technology plans to repurchase shares worth between 75 million and 150 million yuan, aimed at employee stock ownership plans or equity incentives [10] Group 4 - BeiLu Pharmaceutical's subsidiary received approval for the raw material drug Iopromide, which is used as a contrast agent for various imaging examinations [12] - HongHui New Materials obtained a patent for a water-based protective paint for hardware parts, enhancing its product portfolio [13] - BoJi Pharmaceutical's subsidiary received two patents related to high bioavailability formulations, indicating innovation in biopharmaceutical technology [14] Group 5 - ChengJian Development received a cash dividend of 23.625 million yuan from its investment in Huaneng Capital, contributing to its investment income [15] - JiuZhou Pharmaceutical's subsidiary received a drug registration certificate for Sildenafil Citrate orally disintegrating tablets, expanding its product offerings in the erectile dysfunction treatment market [16] - RuiAng Gene's subsidiary received a government subsidy of 176,290 yuan, supporting its operational activities [17] Group 6 - FengFan Technology plans to acquire 100% equity of a subsidiary for 48 million yuan, indicating strategic expansion in the renewable energy sector [18] - AoJing Medical's subsidiary received a medical device production license, allowing it to manufacture absorbable surgical dressings [19] - TaiLin Bio's subsidiary won land use rights for an industrial site, facilitating its high-performance filter project [20] Group 7 - KaiPu Bio received a patent for a method and device for analyzing genomic copy number variations, enhancing its capabilities in molecular diagnostics [21] - Shanghai KaiBao received a drug registration certificate for Phlegm-Heat Clearing Capsules, which can be used in the treatment of COVID-19 symptoms [23] - TuoJing Life received two patents for high uniformity streptavidin applications, improving its diagnostic product stability [25] Group 8 - AnKe Bio's AK2024 injection received approval for clinical trials, marking a significant advancement in cancer treatment [26] - HuanYuan Pharmaceutical expects a net profit of 142 million to 160 million yuan for the first half of 2025, reflecting substantial growth [27] - JinHongShun terminated a major asset restructuring plan due to a lack of consensus among parties involved, impacting its strategic direction [28] Group 9 - HeZhan Energy signed a 177 million yuan contract for the sale of steel-concrete tower structures, indicating strong demand in the renewable energy sector [29] - InSai Group's acquisition plan for an 80% stake in ZhiZheTongXing was accepted by the Shenzhen Stock Exchange, indicating growth in its consulting business [30] - JiuDian Pharmaceutical received a drug registration certificate for Zinc Granules, enhancing its product line in gastrointestinal treatments [32] Group 10 - GuoYao Modern plans to publicly transfer a 51% stake in its subsidiary to optimize resource allocation [34] - GuoYao Modern's subsidiary received a drug registration certificate for Perindopril Indapamide tablets, expanding its hypertension treatment portfolio [36] - ZhongGong International signed a 175 million yuan engineering consulting service contract, showcasing its capabilities in project management [38] Group 11 - China Railway won contracts worth approximately 5.343 billion yuan for overseas construction projects, indicating its strong international presence [39] - JunPu Intelligent signed a framework contract for humanoid robot sales worth about 28.25 million yuan, reflecting growth in the robotics sector [41] - Sinopec's chairman resigned due to age, which may lead to changes in corporate governance [42] Group 12 - JiuFeng Energy's controlling shareholder plans to reduce their stake by up to 0.71%, indicating potential changes in ownership structure [44] - Zhejiang Oriental's subsidiary plans to establish a 1.74 billion yuan equity investment fund, focusing on strategic emerging industries [46] - ChenGuang New Materials received a government subsidy of 26 million yuan, significantly impacting its financial performance [48]

证券代码：601700 证券简称：风范股份 公告编号：2025-037 常熟风范电力设备股份有限公司 关于上海瑞力新兴产业投资基金（有限合伙） 拟进行清算的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 常熟风范电力设备股份有限公司（以下简称"公司"） 于 2025 年 6 月 30 日 召开第六届董事会第十四次会议，审议通过了《关于上海瑞力新兴产业投资基金 （有限合伙）清算的议案》，同意对上海瑞力新兴产业投资基金（有限合伙）进 行清算。本事项尚需提交股东会审议。 公司参与设立的上海瑞力新兴产业投资基金（有限合伙）（以下简称"瑞力基 金"）存续期限将于 2025 年 7 月 8 日期满。根据《中华人民共和国合伙企业法》 及《上海瑞力新兴产业投资基金（有限合伙）有限合伙协议》（以下简称"《合伙 协议》"）的有关规定，瑞力基金普通合伙人上海瑞久投资管理合伙企业（有限 合伙）拟作为基金的清算人，将对瑞力基金进行清算。现将有关情况提示公告如 下： 一、基本情况概述 1、公司于 2012 年 6 月 13 日召开第一届 ...

证券代码：601700 证券简称：风范股份 公告编号：2025-036 常熟风范电力设备股份有限公司 关于拟购买董监高责任险的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 为进一步完善公司风险管理体系，降低运营风险，促进董事、监事及高级管 理人员在其职责范围内更充分地行使权利、履行职责，保障公司和广大投资者的 权益，根据《公司法》《上市公司治理准则》等相关规定，公司拟为公司及全体 董事、监事和高级管理人员购买责任险（具体以最终签署的合同为准）。 二、董监高责任险方案 1、投保人：常熟风范电力设备股份有限公司 2、被保险人：公司及全体董事、监事、高级管理人员及其他相关人员（具 体以保险合同为准） 3、赔偿限额：不超过人民币 10000 万元（具体以保险合同为准） 4、保费限额：不超过人民币 30 万元/年（具体以保险合同为准） 5、保险期限：12 个月（授权有效期内每年可续保或重新投保） 为提高决策效率，董事会提请公司股东大会授权公司管理层在上述权限内办 理董事、监事及高级管理人员责任保险购买的相关事宜（包括但不限 ...

证券代码：601700 证券简称：风范股份 公告编号：2025-038 常熟风范电力设备股份有限公司 关于收购控股公司下属项目公司 100%股权的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、本次交易概述 （一）本次交易的基本情况 公司拟与控股子公司苏州晶樱光电科技有限公司（以下简称"晶樱光电"）签 署《股权转让协议》，以自有资金人民币 4800 万元收购晶樱光电下属全资孙公 司扬州旭樱新能源科技有限公司（以下简称"扬州旭樱"）及其下属全资公司的 8 个光伏电站项目公司 100%股权，具体交易情况如下： | 序 | 标的公司 | 母公司 | 持股比例 | 装机量 | 净资产账 面价值 | 评估值 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 号 | | | | （兆瓦） | | （万元） | 报告号 | | | | | | | （万元） | | | | 1 | 徐州唐立光电科技 | 扬州旭樱 | 100% | 6.47 | 36.78 | 65 ...

证券代码：601700 证券简称：风范股份 公告编号：2025-035 常熟风范电力设备股份有限公司 关于确认业绩补偿金额及业绩补偿进展的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、业绩承诺基本情况 根据常熟风范电力设备股份有限公司（以下简称"公司"）与业绩承诺人黄金 强、韩莉莉签署的《常熟风范电力设备股份有限公司与黄金强之盈利预测补偿协 议》及补充协议，业绩承诺人承诺晶樱光电 2023 年度和 2024 年度实现扣非后 归属于母公司所有者的净利润合计数不低于 32,000.00 万元。自 2023 年 1 月 1 日至 2024 年 12 月 31 日止，若晶樱光电累计实现扣非后归属于母公司所有者的 净利润数低于 32,000.00 的 85%即 27,200.00 万元，黄金强、韩莉莉同意对风 范股份进行补偿。补偿金额计算方式为：应补偿的金额=(累计承诺净利润-累计 实现净利润)/累计承诺净利润 x 甲方已收购乙方在本次交易项下直接及间接持有 的标的公司股权对应的收购对价总和。计算的补偿金额小于 0 时 ...

3、本次董事会会议于 2025 年 6 月 30 日在公司三楼会议室以现场及通讯表 决方式召开。 证券代码：601700 证券简称：风范股份 公告编号：2025-033 常熟风范电力设备股份有限公司 第六届董事会第十四次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、董事会会议召开情况 1、常熟风范电力设备股份有限公司（以下简称"公司"）第六届董事会第十 四次会议的召开符合有关法律、行政法规、部门规章、规范性文件和公司章程的 规定。 2、本次董事会会议通知和议案材料于 2025 年 6 月 24 日以微信形式送达全 体董事。 3、审议通过了《关于购买董监高责任险的议案》 4、本次董事会会议应参加董事 13 人，实际参加董事 13 人。 5、本次董事会会议由董事长王建祥先生主持，公司监事和高级管理人员列 席了会议。 二、董事会会议审议情况 1、审议通过了《关于确认业绩补偿金额的议案》 根据公司与业绩承诺人黄金强、韩莉莉签署的《常熟风范电力设备股份有限 公司与黄金强之盈利预测补偿协议》及补充协议的业绩补偿条 ...

证券代码：601700 证券简称：风范股份 公告编号：2025-039 常熟风范电力设备股份有限公司 关于以集中竞价方式回购股份的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 公司将严格按照《上市公司股份回购规则》《上海证券交易所上市公司自律 监管指引第7号——回购股份》等相关规定，在回购期限内根据市场情况择机做 出回购决策并予以实施，同时根据回购股份事项进展情况及时履行信息披露义务， 敬请广大投资者注意投资风险。 特此公告。 | 回购方案首次披露日 | 年 2024 13 | 11 | 月 | 日 | | | --- | --- | --- | --- | --- | --- | | 回购方案实施期限 | 待董事会审议通过后 个月 12 | | | | | | 方案日期 | 年 2024 12 | 11 | 月 | 日 | | | 预计回购金额 | 亿元~3 亿元 1.5 | | | | | | 回购资金来源 | 自有资金及专项回购贷款 | | | | | | 回购价格上限 | 6.90 元/股 | | | ...

本报告依据中国资产评估准则编制 风范新能源(苏州)有限公司拟股权 股东全部权益价值 中国资产评估协会 资产评估业务报告备案回执 | 报告编码: | 4711020080202501443 | | --- | --- | | 合同编号: | NKG[2025]第 1523 号 | | 报告类型: | 法定评估业务资产评估报告 | | 报告文号: | 北方亚事评报字[2025]第 01-0800 号 | | 报告名称: | 风范新能源(苏州)有限公司拟股权收购涉及的岳 | | | 阳绿晶新能源有限公司股东全部权益价值 | | 评估结论: | 10,880,000.00 元 | | 评估报告日: | 2025 年 | | 评估机构名称: | 北方亚 八百 | | 签名人员: | 张冉 编号:32190192 | | | 王珊瑚 会员编号:32180019 | | | (可扫描二维码查询备案业务信息) | 说明:报告备案回执仅证明此报告已在业务报备管理系统进行了备案,不 作为协会对该报告认证、认可的依据,也不作为资产评估机构及其签字资产评 估专业人员免除相关法律责任的依据。 备案回执生成日期:2025-06-19 资 ...

本报告依据中国资产评估准则编制 风范新能源（苏州）有限公司拟股权 收购涉及的邵阳市千进新能源有限公司 股东全部权益价值 资产评估报告 北方亚事评报字[2025]第01-0801号 行十分 NT CO.,LTD 中国资产评估协会 说明:报告备案回执仅证明此报告已在业务报备管理系统进行了备案,不 作为协会对该报告认证、认可的依据,也不作为资产评估机构及其签字资产评 估专业人员免除相关法律责任的依据。 备案回执生成日期:2025-06-19 风范新能源(苏州)有限公司拟股权收购涉及的 邵阳市千进新能源有限公司股东全部权益价值资产评估报告 | | 1 | | --- | --- | | ﻢ œ 7 | K | | 들 明 . | | | --- | --- | | 资产评估报告摘要 . | | | 资产评估报告正文 . | 5 | | 一、委托人、被评估单位和委托人以外的其他评估报告使用者 5 | | | 二、评估目的 10 | | | 三、评估对象和评估范围 10 | | | 四、价值类型 12 | | | 五、评估基准目 12 | | | 六、评估依据 13 | | | 七、评估方法 15 | | | 21 八、 ...